1. Home
  2. Labeler Index
  3. Nucare Pharmaceuticals,inc.
  4. 68071-4470
  5. Product Images: Carvedilol

Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Carvedilol NDC 68071-4470 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

68071 4470 9

68071 4470 9

This is a description of Carvedilol 25mg tablets made by a company named "are Pharmaceuticals, Inc", with a National Drug Code of 68071-4470-9, and manufactured by NDC 65862-145-05. The tablets are oval-shaped, white/off-white and film-coated. Each tablet contains 25mg of Carvedilol, a medicine used to treat heart failure and high blood pressure. The lot number is 000000, and the tablets have an expiration date of 00-00. The product should be stored at 68-77°F and kept out of reach of children. The text also provides a warning to seek medical advice if there are any side effects and a phone number to contact the FDA to report side effects.*

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

This is a figure from a study called COPERNICUS that shows the effects of spironolactone on mortality in different subgroups of patients. The subgroups are divided by gender, age, race, diabetes status, ischemic status, heart failure severity, heart rate, blood pressure, and whether or not the patient was taking spironolactone. The figure displays hazard ratios on the x-axis and subgroups on the y-axis. There are no readable values for hazard ratios or y-axis subgroups in the text, so the details of the results are not available.*

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Chemical Structure - carvedilol str

Chemical Structure - carvedilol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.